Immunonutrition in the critically ill: A systematic review of clinical outcome

被引:311
作者
Beale, RJ
Bryg, DJ
Bihari, DJ
机构
[1] St Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Intens Care, London SE1 7EH, England
[2] Inst Med Outcome Res, Lorrach, Germany
[3] Prince Wales Hosp, Adult Intens Care Unit, Sydney, NSW, Australia
基金
巴西圣保罗研究基金会; 美国国家卫生研究院;
关键词
enteral nutrition; arginine; glutamine; intensive care; immune system; omega-3 fatty acids; nucleotides; sepsis; critical illness; meta-analysis;
D O I
10.1097/00003246-199912000-00032
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To perform a meta-analysis addressing whether enteral nutrition with immune-enhancing feeds benefits critically ill patients after trauma, sepsis, or major surgery. Data Sources: Studies were identified by MEDLINE search (1967 to January 1998) for original articles in English using the search terms "human," "enteral nutrition," "arginine," "nucleotides," "omega-3 fatty acids," "immunonutrition," "IMPACT," and "Immun-Aid." Additionally, the authors of the studies and the manufacturers of the feeds were contacted for additional information. Access to original databases was obtained for the three largest studies. Study Selection: Fifteen randomized controlled trials comparing patients receiving standard enteral nutrition with patients receiving a commercially available immune-enhancing feed with arginine with or without glutamine, nucleotides, and omega-3 fatty acids were identified by two independent reviewers (Dr. Beale and Dr. Bryg). Data Extraction: Descriptive and outcome data were extracted independently from the papers by the same two reviewers, one of whom (Dr. Bryg) analyzed the original databases. Three studies were excluded from analysis, leaving 12 studies containing 1,557 subjects, 1,482 of whom were analyzed. Main outcome measures were mortality, infection, ventilator days, intensive care unit stay, hospital stay, diarrhea days, calorie intake, and nitrogen intake. The meta-analysis was performed on an intent-to-treat basis. Data Synthesis: There was no effect of immunonutrition on mortality (relative risk = 1.05, confidence interval [CI] = 0.78, 1.41; p = .76). There were significant reductions in infection rate (relative risk = 0.67, CI = 0.50, 0.89; p = .006), ventilator days (2.6 days, CI = 0.1, 5.1; p = .04), and hospital length of stay (2.9 days, CI = 1.4, 4.4; p = .0002) in the immunonutrition group. Conclusions: The benefits of enteral immunonutrition were most pronounced in surgical patients, although they were present in all groups. The reduction in hospital length of stay and infections has resource implications.
引用
收藏
页码:2799 / 2805
页数:7
相关论文
共 28 条
  • [1] [Anonymous], LANCET
  • [2] A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill
    Atkinson, S
    Sieffert, E
    Bihari, D
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (07) : 1164 - 1172
  • [3] BALLAR JC, 1997, NEW ENGL J MED, V337, P559
  • [4] Barton R G, 1997, Nutr Clin Pract, V12, P51, DOI 10.1177/011542659701200251
  • [5] EARLY ENTERAL ADMINISTRATION OF A FORMULA (IMPACT((R))) SUPPLEMENTED WITH ARGININE, NUCLEOTIDES, AND FISH-OIL IN INTENSIVE-CARE UNIT PATIENTS - RESULTS OF A MULTICENTER, PROSPECTIVE, RANDOMIZED, CLINICAL-TRIAL
    BOWER, RH
    CERRA, FB
    BERSHADSKY, B
    LICARI, JJ
    HOYT, DB
    JENSEN, GL
    VANBUREN, CT
    ROTHKOPF, MM
    DALY, JM
    ADELSBERG, BR
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (03) : 436 - 449
  • [6] BRAGA M, 1995, INFUSIONSTHERAPIE, V22, P280
  • [7] Artificial nutrition after major abdominal surgery: Impact of route of administration and composition of the diet
    Braga, M
    Gianotti, L
    Vignali, A
    Cestari, A
    Bisagni, P
    Di Carlo, V
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (01) : 24 - 30
  • [8] CERRA FB, 1990, NUTRITION, V6, P84
  • [9] A METHOD FOR ASSESSING THE QUALITY OF A RANDOMIZED CONTROL TRIAL
    CHALMERS, TC
    SMITH, H
    BLACKBURN, B
    SILVERMAN, B
    SCHROEDER, B
    REITMAN, D
    AMBROZ, A
    [J]. CONTROLLED CLINICAL TRIALS, 1981, 2 (01): : 31 - 49
  • [10] DALY JM, 1992, SURGERY, V112, P56